Search research articles
Contact Us
Filters
Showing results (11-20 of 37) with videos related to
Page
of 4
Sort By:
Journal of Clinical Medicine
|
June 2, 2021
Oncological Frontiers in the Treatment of Malignant Pleural Mesothelioma
Emanuele Vita, Alessio Stefani, Mariantonietta Di Salvatore, et al.
Expert Review of Anticancer Therapy
|
June 16, 2024
The incidence and relative risk of major adverse cardiovascular events and hypertension in patients treated with immune checkpoint inhibitors plus tyrosine-kinase inhibitors for solid tumors: a systemic review and meta-analysis
Chiara Ciccarese, Annunziato Anghelone, Alessio Stefani, et al.
Optics Express
|
September 13, 2019
Towards subdiffraction imaging with wire array metamaterial hyperlenses at MIR frequencies
Juliano G Hayashi, Alessio Stefani, Sergei Antipov, et al.
Future Oncology (London, England)
|
March 6, 2024
Response to first-line pembrolizumab in metastatic <i>KRAS</i>-mutated non-small-cell lung cancer
Sabrina Rossi, Arianna Pagliaro, Giovanna Finocchiaro, et al.
Cancers
|
May 25, 2024
Implementation of Artificial Intelligence in Personalized Prognostic Assessment of Lung Cancer: A Narrative Review
Filippo Lococo, Galal Ghaly, Marco Chiappetta, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials
|
October 19, 2020
Thermally drawn biodegradable fibers with tailored topography for biomedical applications
Syamak Farajikhah, Antoine F J Runge, Badwi B Boumelhem, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 8, 2025
Complete Response to Lorlatinib in Lung Adenocarcinoma With EML4-ALK Fusion Variant (E6;A18): Case Report and Literature Review
Antonio Vitale, Elisa De Paolis, Jacopo Russo, et al.
Cancers
|
July 2, 2021
Early Progression in Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Treated with Pembrolizumab in First-Line Setting: A Prognostic Scoring System Based on Clinical Features
Antonio Passaro, Silvia Novello, Diana Giannarelli, et al.
Vaccines
|
April 23, 2025
COVALENCE STUDY: Immunogenicity and Reactogenicity of a COVID-19 mRNA Vaccine in an Open-Label Cohort of Long-Survivor Patients with Metastatic Lung Cancer
Emanuele Vita, Federico Monaca, Luca Mastrantoni, et al.
Frontiers in Oncology
|
July 30, 2025
Enhanced response to dabrafenib plus trametinib in a patient with <i>BRAF</i> <sup>V600E</sup> lung cancer harboring an <i>RNF43</i> variant of unknown significance: a case report
Ettore D'Argento, Antonio Vitale, Jacopo Russo, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 37) with videos related to
Sort By:
Page
of 4
Journal of Clinical Medicine
|
June 2, 2021
Oncological Frontiers in the Treatment of Malignant Pleural Mesothelioma
Emanuele Vita, Alessio Stefani, Mariantonietta Di Salvatore, et al.
Expert Review of Anticancer Therapy
|
June 16, 2024
The incidence and relative risk of major adverse cardiovascular events and hypertension in patients treated with immune checkpoint inhibitors plus tyrosine-kinase inhibitors for solid tumors: a systemic review and meta-analysis
Chiara Ciccarese, Annunziato Anghelone, Alessio Stefani, et al.
Optics Express
|
September 13, 2019
Towards subdiffraction imaging with wire array metamaterial hyperlenses at MIR frequencies
Juliano G Hayashi, Alessio Stefani, Sergei Antipov, et al.
Future Oncology (London, England)
|
March 6, 2024
Response to first-line pembrolizumab in metastatic <i>KRAS</i>-mutated non-small-cell lung cancer
Sabrina Rossi, Arianna Pagliaro, Giovanna Finocchiaro, et al.
Cancers
|
May 25, 2024
Implementation of Artificial Intelligence in Personalized Prognostic Assessment of Lung Cancer: A Narrative Review
Filippo Lococo, Galal Ghaly, Marco Chiappetta, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials
|
October 19, 2020
Thermally drawn biodegradable fibers with tailored topography for biomedical applications
Syamak Farajikhah, Antoine F J Runge, Badwi B Boumelhem, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 8, 2025
Complete Response to Lorlatinib in Lung Adenocarcinoma With EML4-ALK Fusion Variant (E6;A18): Case Report and Literature Review
Antonio Vitale, Elisa De Paolis, Jacopo Russo, et al.
Cancers
|
July 2, 2021
Early Progression in Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Treated with Pembrolizumab in First-Line Setting: A Prognostic Scoring System Based on Clinical Features
Antonio Passaro, Silvia Novello, Diana Giannarelli, et al.
Vaccines
|
April 23, 2025
COVALENCE STUDY: Immunogenicity and Reactogenicity of a COVID-19 mRNA Vaccine in an Open-Label Cohort of Long-Survivor Patients with Metastatic Lung Cancer
Emanuele Vita, Federico Monaca, Luca Mastrantoni, et al.
Frontiers in Oncology
|
July 30, 2025
Enhanced response to dabrafenib plus trametinib in a patient with <i>BRAF</i> <sup>V600E</sup> lung cancer harboring an <i>RNF43</i> variant of unknown significance: a case report
Ettore D'Argento, Antonio Vitale, Jacopo Russo, et al.
Page
of 4